Publications by authors named "Xavier Chamillard"

Background And Aims: Several symptomatic cases of HEV infections were reported to the New Caledonia Island Public Health Service between August and December 2023. This prompted epidemiological and virological investigations to identify the source of infection.

Approach And Results: HEV RNA was assessed in symptomatic patients, various food items, and pig farms on the Island.

View Article and Find Full Text PDF
Article Synopsis
  • Positive direct antiglobulin tests (DATs) were found in a study on post-artesunate delayed hemolysis (PADH), but the relationship between DAT positivity and PADH is not clear.
  • In a 7-year study of 337 severe malaria patients treated with artesunate, 54.3% of those who had DAT results experienced positive results, yet this did not correlate with the occurrence of PADH.
  • The findings suggest that DAT positivity is not a reliable marker for PADH and should not prompt the use of corticosteroids in treatment.
View Article and Find Full Text PDF

Background: Management of the increasing number of sensitized heart transplant candidates has become a recurrent issue. Rather than using pretransplant desensitization therapies, we used a posttransplant prophylactic strategy. Our aim was to describe outcomes in transplant recipients with preformed donor-specific anti-HLA antibodies (pfDSA) managed with this strategy.

View Article and Find Full Text PDF

Background: Red blood cell (RBC) Thomsen-Friedenreich antigen exposure (T activation) in infants with necrotizing enterocolitis (NEC) has occasionally been associated with posttransfusional intravascular hemolysis thought to be due to anti-T antibodies in the donor plasma.

Study Design And Methods: We describe an infant with NEC and Clostridium perfringens infection complicated by severe hemolysis after plasma transfusion. After this case, infants with confirmed NEC were prospectively evaluated for T activation.

View Article and Find Full Text PDF

Background: Sickle cell disease (SCD) has become a major public health issue. Hydroxyurea and red blood cell (RBC) transfusion are the cornerstone treatments. Erythrocytapheresis (ECP) is an automated method for transfusion exchange.

View Article and Find Full Text PDF